Pharmaceutical industry payments to Australian healthcare professionals (October 2015 to October 2018)

About the project This project stems from the Evidence, Policy and Influence Collaborative, led by Prof Lisa Bero, which seeks to translate rigorous and unbiased evidence into clinical practice and health policy. One facet of this Collaborative is the study of bias in healthcare: we sought to understand the extent of pharmaceutical industry marketing in the form of payments to health professionals as a means to begin tracing the influence of marketing on clinical care.

About the Dataset
The dataset contains pharmaceutical company reports of payments to Australian healthcare professionals for theprovision of services or sponsorship of medical education, including airfares, accommodation and registration fees. Itcollates 200 publicly available reports submitted to Medicines Australia by 35 companies between 1 October 2015and 31 October 2018.